| ²é¿´: 935 | »Ø¸´: 8 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
ʯ׳½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
10ËêµÜµÜÍÑ·¢ºÜÑÏÖØ£¬Çó°ïÖú ÒÑÓÐ4È˲ÎÓë
|
|
| RT£¬µÜµÜ½ñÄê²ÅÊ®Ë꣬ÕýÔÚÉÏСÁù¡£¡£×î½üÒ»¸öÔ·¢ÏÖ£¬ËûµÄÍ··¢µôµÄºÜÀ÷º¦£¬ÒòΪ¼Ò¾³»¹²»´í£¬ËùÒÔÓªÑø·½Ã滹ÊDz»´íµÄ£¬Ï´·¢Ë®Ò²ÊÇÓõÄÇåÑïÒ»ÀàÕý¹æÅÆ×ӵġ£ÓÉÓÚÔÚÇà´ºÆÚ£¬Õý´¦ÓÚÉíÌå·¢Óý¡¢ÖÇÁ¦·¢Óý±È½Ï¹Ø¼üµÄʱÆÚ£¬ËùÒÔ¼ÒÈËÌØ±ðµØ×ż±ÉÏ»ð£¬ÓÈÆäÊÇËûÂèÂè¡£¡£Ï£ÍûÓÐÆ¤·ô¿ÆµÄ³æÓÑÄܹ»¾ÍרҵÐÔÌá³ö½â´ð£¬Ôڴ˷dz£¸Ðл¡£¡£¡£ |
» ²ÂÄãϲ»¶
ÆÚ¿¯Letters in drug design & discoveryͶ¸åÇóÖú
ÒѾÓÐ10È˻ظ´
ÆÚ¿¯Letters in drug design & discoveryͶ¸åÇóÖú
ÒѾÓÐ0È˻ظ´
ҽѧÃâÒßѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ86È˻ظ´
»¤Àíר˶304·Ö£¬´óѧËÄÄê³É¼¨¾ùΪרҵµÚÒ»£¡Çóµ÷¼Á£¡
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ºÓÄÏ´óѧ»¤Àíר˶£¡À´¸öÀÏʦÊÕÁôÎÒ£¬¾ø²»»áºó»Ú£¡
ÒѾÓÐ5È˻ظ´
ҽѧ¿¼Ñе÷¼Á
ÒѾÓÐ1È˻ظ´
ÎÄÏ×ÇóÖú£¬¼±¼±¼±£¡£¡£¡£¡
ÒѾÓÐ2È˻ظ´
ʯ׳
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 840.2
- É¢½ð: 347
- ºì»¨: 1
- Ìû×Ó: 135
- ÔÚÏß: 150.6Сʱ
- ³æºÅ: 1298561
- ×¢²á: 2011-05-17
- רҵ: »·¾³¹¤³Ì
3Â¥2014-09-21 19:09:38
cyx5233
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 2613
- ºì»¨: 1
- Ìû×Ó: 1360
- ÔÚÏß: 104.7Сʱ
- ³æºÅ: 1702594
- ×¢²á: 2012-03-19
- רҵ: Óлú»¯Ñ§
2Â¥2014-09-21 13:55:49
dlc2008
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 421.7
- É¢½ð: 10
- Ìû×Ó: 216
- ÔÚÏß: 212.7Сʱ
- ³æºÅ: 1367676
- ×¢²á: 2011-08-13
- רҵ: ΢/ÄÉ»úеϵͳ
4Â¥2014-09-21 20:07:16
myyounger
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ¹ó±ö: 0.105
- ½ð±Ò: 23288.5
- É¢½ð: 500
- ºì»¨: 144
- Ìû×Ó: 16619
- ÔÚÏß: 484.6Сʱ
- ³æºÅ: 638546
- ×¢²á: 2008-10-28
- רҵ: ÄÔѪ¹Ü½á¹¹¡¢¹¦ÄÜÒì³£¼°Ïà
5Â¥2014-09-22 18:02:13













»Ø¸´´ËÂ¥